
Apyx Medical Corporation: updates and filings
Price
$2.81
November 13, 2026Market cap $118M
What Ploutos Investor adds for Apyx Medical
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Oct 28, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 29, 2026Other material eventsForm8-K
- Aug 7, 2026Officer or director change, shareholder voteForm8-K
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 24, 2026Other material eventsForm8-K
- Jul 21, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jun 26, 2026Annual meeting proxy statementFormDEF 14A
- Jun 17, 2026Material agreement enteredForm8-K
- Jun 1, 2026Conflict minerals reportFormSD
- May 21, 2026Other material eventsForm8-K
- May 14, 2026Other material eventsForm8-K
- May 11, 2026Other material eventsForm8-K
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 7, 2026Results of operationsForm8-K
- Mar 10, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 10, 2026Results of operationsForm8-K
- Feb 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 20, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 12, 2026Results of operationsForm8-K
- Dec 16, 2025FilingFormEFFECT
- Dec 12, 2025Amended articles or bylawsForm8-K
- Dec 12, 2025Correspondence with the SECFormCORRESP
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Oct 28, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 29, 2026 | 8-K | Other material events | Document |
| Aug 7, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 24, 2026 | 8-K | Other material events | Document |
| Jul 21, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jun 26, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Jun 17, 2026 | 8-K | Material agreement entered | Document |
| Jun 1, 2026 | SD | Conflict minerals report | Document |
| May 21, 2026 | 8-K | Other material events | Document |
| May 14, 2026 | 8-K | Other material events | Document |
| May 11, 2026 | 8-K | Other material events | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 7, 2026 | 8-K | Results of operations | Document |
| Mar 10, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 10, 2026 | 8-K | Results of operations | Document |
| Feb 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 20, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 12, 2026 | 8-K | Results of operations | Document |
| Dec 16, 2025 | EFFECT | Filing | Document |
| Dec 12, 2025 | 8-K | Amended articles or bylaws | Document |
| Dec 12, 2025 | CORRESP | Correspondence with the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 21, 1995.
The full analysis
What do Apyx Medical's filings show?
The filings are where every one of Apyx Medical's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.